Pacific Edge Ltd (PEB) Stock Price & News

Pacific Edge Limited, based in New Zealand, focuses on cancer diagnostics with a suite of bladder cancer diagnostic tools using genetic biomarkers. The company operates with a head office in Dunedin, New Zealand, and also has an office in Hershey, USA. It is listed on the Australian ASX and the New Zealand NZX main board stock exchange. Wikipedia

About Pacific Edge Ltd

CEO-

Employees114

Founded2001

Headquarters-

Sector-

Websitepacificedgedx.com

All values in NZD	Jun. 2025	Sep. 2025	Des. 2025	Mrt. 2026
Revenue	3,42 m	3,42 m	3,09 m	3,09 m
Cost of goods sold	2,94 m	2,94 m	2,86 m	2,86 m
Cost of revenue	2,94 m	2,94 m	2,86 m	2,86 m
Research and development expenses	3,53 m	3,53 m	3,18 m	3,18 m
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	6,64 m	6,64 m	5,52 m	5,52 m
Operating expense	10,18 m	10,18 m	8,70 m	8,70 m
Total operating expenses	13,12 m	13,12 m	11,56 m	11,56 m
Operating income	-9,70 m	-9,70 m	-8,47 m	-8,47 m
Other non operating income	-	-	-	-
EBT including unusual items	-9,56 m	-9,56 m	-8,33 m	-8,33 m
EBT excluding unusual items	-9,56 m	-9,56 m	-8,36 m	-8,36 m
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-
Net income	-9,56 m	-9,56 m	-8,33 m	-8,33 m
Net profit margin	-279,64%	-279,64%	-269,79%	-269,79%
Earnings per share	-	-	-	-
Interest and investment income	149,50 k	149,50 k	111,00 k	111,00 k
Interest expense	-	-	-	-
Net interest expenses	149,50 k	149,50 k	111,00 k	111,00 k
Depreciation and amortization charges	-	-	-	-
EBITDA	-9,40 m	-9,40 m	-8,34 m	-8,34 m
Gain or loss from assets sale	-11,50 k	-11,50 k	6,50 k	6,50 k

Ask anything